Immune checkpoint inhibitors of CTLA4 and PD-1 for malignant melanoma arising in ovarian cystic teratoma: A case report

RATIONALE: Malignant melanoma (MM) arising in ovarian cystic teratoma (OCT) is a rare disease with poor prognosis. Recently, immune checkpoint inhibitors of cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) and programmed death 1 (PD-1) have shown promising results in MM. Herein we report a case o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yano, Mitsutake, Asami, Yuri, Nishikawa, Tadaaki, Yoshida, Saori, Kamada, Kouichi, Katoh, Tomomi, Teramoto, Yukiko, Nakamura, Yasuhiro, Yasuda, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221685/
https://www.ncbi.nlm.nih.gov/pubmed/30412106
http://dx.doi.org/10.1097/MD.0000000000012937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221685/
https://www.ncbi.nlm.nih.gov/pubmed/30412106
http://dx.doi.org/10.1097/MD.0000000000012937

Ejemplares similares